# US 7,488,601 B2 · System and method for determining an abused sensor during analyte measurement

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 7,488,601 B2
- Document ID: US7488601B2
- Status: Granted
- Kind: B2
- Application number: 10/688,561
- Filed: 2003-10-17
- Published: 2004-12-23
- Granted: 2009-02-10
- Earliest claimed: 2003-06-20
- Assignees: Roche Diagnostic Operations, Inc.; Roche Operations Ltd.
- Inventors: David W. Burke; Lance S. Kuhn; James Maxwell
- Web page: https://patentgrep.com/patent/US7488601B2

## CPC

- G01N 27/3274: {Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration (coding of calibration information G01N33/48771)}
- G01N 27/121: {for determining moisture content, e.g. humidity, of the fluid (moisture content of the tested material G01N27/048)}
- G01N 27/02: by investigating impedance
- Y10T 436/11: Automated chemical analysis
- Y10T 436/112499: with sample on test slide
- Y10T 436/142222: Hetero-O [e.g., ascorbic acid, etc.]
- Y10T 436/143333: Saccharide [e.g., DNA, etc.]
- Y10T 436/144444: Glucose
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

A method of measuring an analyte in a biological fluid comprises applying an excitation signal having a DC component and an AC component. The AC and DC responses are measured; a corrected DC response is determined using the AC response; and a concentration of the analyte is determined based upon the corrected DC response. Other methods and devices are disclosed.

## Claims

### Claim 1

A method for detecting an abused sensor adapted for determining a concentration of a medically significant component of a biological fluid, comprising the steps of:
a) applying a signal having an AC component to the sensor;
b) measuring an AC response to the signal; and
c) using the AC response to determine if the sensor is abused, wherein steps (a), (b) and (c) are performed before application of the biological fluid to the sensor.

### Claim 2 (depends on 1)

The method of claim 1, wherein the AC response comprises an admittance.

### Claim 3 (depends on 1)

The method of claim 1, wherein the signal is an AC signal.

### Claim 4 (depends on 1)

The method of claim 1, wherein the AC response comprises phase angle information.

### Claim 5 (depends on 1)

The method of claim 1, wherein the AC component of the signal has a frequency not less than 1 Hz and not greater than 20 kHz.

### Claim 6 (depends on 1)

The method of claim 1, wherein the biological fluid is blood.

### Claim 7

A method for detecting an abused sensor for determining a concentration of a medically significant component of a biological fluid placed upon the sensor, comprising the steps of:
a) placing the biological fluid sample upon the sensor;
b) applying a first signal to the biological fluid;
c) measuring a current response to the first signal;
d) repeating step (c) at least once;
e) calculating a normalized Cottrell Failsafe Ratio using the current response data;
f) applying a second signal having an AC component to the biological fluid;
g) measuring an AC response to the second signal; and
h) combining the normalized Cottrell Failsafe Ratio and the AC response to produce an indication of whether the sensor has been abused, wherein step (h) comprises calculating a FAILSAFE number as follows:
FAILSAFE=1000×arctan [NCFR/(fs0+fs1(Φ1−Φ2))]
where: 1000=scaling factor
NCFR normalized Cottrell Failsafe Ratio
fs0=constant
fs1=constant
Φ1=phase angle at a first frequency
Φ2=phase angle at a second frequency;
wherein a value of FAILSAFE below zero indicates an abused sensor and a value of FAILSAFE above zero indicates a non-abused sensor.

### Claim 8

A method of determining a failure condition indicating an abused sensor in a blood glucose concentration test, comprising the steps of:
a) applying a first test signal having an AC component to a test sample;
b) measuring a first phase angle response to the first test signal;
c) applying a second test signal having an AC component to the test sample;
d) measuring a second phase angle response to the second test signal; and
e) determining a failure condition value based upon the first phase angle response the second phase angle response and a predetermined Cottrell Failsafe Ratio, wherein step (e) is performed based at least in part upon evaluating:
arctan [CFR/(fs0+fs1(ΦA−ΦB)]
where:
CFR=Cottrell Failsafe Ratio
fs0=a constant
fs1=a constant
ΦA=first phase angle response
ΦB=second phase angle response.
